Form 10-Q · Quarterly report
Microchip Technology 10-Q, filed Aug 6, 2026
- Filed
- CIK
- 0000827054
- Accession no.
- 0000827054-26-000038
Summary
Microchip Technology reported sequential growth in net sales across all product lines, geographies and distributor channels for the quarter ended June 30, 2026, along with a sequential decline in inventory days as demand recovered after customers worked down excess inventory. The company said it continues to carry out the restructuring, manufacturing resizing and headcount reductions begun under its March 2025 business recovery plan, while flagging uncertainty from macroeconomic conditions, geopolitical tensions, tariffs and trade policy.
Key points
- Net sales to distributors and in each product line and geography rose sequentially in the June 2026 quarter compared with the March 2026 quarter.
- Inventory days decreased sequentially in the June 2026 quarter.
- Microchip's March 2025 business recovery plan included cost reductions, resized manufacturing operations and lower headcount.
- Microchip said it expects to remain a target of cyber-attacks and that its IT system compromise is not expected to have a material adverse effect on its business.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations Note Regarding Forward-looking Statements This report, including "Part I – Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Part II - Item 1A. Risk Factors" contains certain forward-looking statements that involve risks and uncertainties, including statements regarding our strategy, financial performance and revenue sources. We use words such as "anticipate," "believe," "can," "continue," "could," "expect," "future," "intend," "plan," and similar expressions to identify forward-looking statements. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.